ReviewBiomedicines2021

Accumulated Knowledge of Activin Receptor-Like Kinase 2 (ALK2)/Activin A Receptor, Type 1 (ACVR1) as a Target for Human Disorders.

Takenobu Katagiri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.